Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmacyclics (PCYC) -- Ignore unavailable to you. Want to Upgrade?

To: tnsaf who wrote (237)	11/28/1997 10:30:00 AM
From: Biomaven	Respond to of 717

OFF TOPIC Jason, I actually succumbed to what may be hype and bought some ENMD last week. It sounds like one of those "too good to be true" stories, but I think it may have a Geron type run if the word gets out. Most of the stories I've seen to date haven't mentioned ENMD, but there was one yesterday (NY Times I think) that mentioned them. It's still very early in their story, but I suppose it might make people a tad less enthusiastic about other oncology treatments (like PCYC among a few hundered others). Peter